Spots Global Cancer Trial Database for uterine neoplasms
Every month we try and update this database with for uterine neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Biobehavioral Intervention in Gynecologic Oncology Patients | NCT02454036 | Neoplasms Ovarian Neoplas... Uterine Neoplas... Vulva | BBI interventio... | 21 Years - 80 Years | University of Kentucky | |
| Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms | NCT03624712 | Uterine Neoplas... | uterine neoplas... | 18 Years - | University Hospital Tuebingen | |
| Impact of the COVID-19 Pandemic in Gynecological Oncology | NCT04351139 | Gynecologic Can... Breast Neoplasm... Uterine Neoplas... Ovarian Neoplas... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... | modification of... | 18 Years - | Hospices Civils de Lyon | |
| Acupuncture for Women's Health Conditions | NCT00090389 | Ovarian Neoplas... Endometriosis Pelvic Pain Uterine Neoplas... | Chinese Acupunc... | 18 Years - | National Center for Complementary and Integrative Health (NCCIH) | |
| Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy | NCT00505492 | Uterine Neoplas... | Carboplatin Cisplatin Paclitaxel | - | M.D. Anderson Cancer Center | |
| Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients | NCT02444195 | Uterine Cervica... Uterine Neoplas... Ovarian Neoplas... Urogenital Neop... Fallopian Tube ... | Guided Imagery ... | 18 Years - | University of Michigan | |
| Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial | NCT04679675 | Uterine Cervica... Uterine Neoplas... Genital Neoplas... Urogenital Neop... Neoplasms by Si... Neoplasms Uterine Cervica... Uterine Disease... Cervical Cancer Cervical Dyspla... Human Papilloma... HPV-Related Cer... HPV Infection HPV-Related Mal... | Usual Care Education Direct Mail Opt-in | 30 Years - 64 Years | Kaiser Permanente | |
| A Trial for Patients With Advanced/Recurrent Cervical Cancer | NCT00190983 | Cervical Intrae... Uterine Neoplas... Genital Neoplas... | Pemetrexed | - | Eli Lilly and Company | |
| Retrospective Study of Brachytherapy | NCT05242861 | Brachytherapy Uterine Cervica... Uterine Neoplas... Vulvar Cancer Vaginal Cancer Ovarian Neoplas... Gynecologic Neo... | Brachytherapy | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation | NCT01998854 | Menorrhagia Leiomyoma Uterine Fibroid... Uterine Fibroma Uterine Neoplas... | VizAblate Syste... | 28 Years - | Gynesonics | |
| MRI and Metabolomics Biomarkers for Uterine Malignancy | NCT02528864 | Uterine Neoplas... | 20 Years - 80 Years | Chang Gung Memorial Hospital | ||
| Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations | NCT04579380 | Uterine Neoplas... Uterine Cervica... Biliary Tract N... Urologic Neopla... Carcinoma, Non-... HER2 Mutations ... | tucatinib trastuzumab fulvestrant | 18 Years - | Seagen Inc. | |
| Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma | NCT00050440 | Endometrial Neo... Uterine Neoplas... Genital Neoplas... | Trabectedin Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Magnetic Resonance Imaging Guided Gynecologic Brachytherapy | NCT00112307 | Cervix Neoplasm... Uterine Neoplas... Vaginal Neoplas... Vulvar Neoplasm... | Brachytherapy | 18 Years - | Brigham and Women's Hospital | |
| Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] | NCT03555422 | Endometrial Can... | Selinexor Matching placeb... | 18 Years - | Karyopharm Therapeutics Inc | |
| Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] | NCT03555422 | Endometrial Can... | Selinexor Matching placeb... | 18 Years - | Karyopharm Therapeutics Inc | |
| A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | NCT00628901 | Leiomyoma Uterine Fibroid... Uterine Neoplas... Menorrhagia Leiomyomatosis | Uterine Fibroid... Contour SE™ Mic... Embosphere® Mic... | 18 Years - | Boston Scientific Corporation | |
| Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus | NCT00502203 | Mixed Tumor, Mu... | Carboplatin Paclitaxel | - | M.D. Anderson Cancer Center | |
| Acupuncture for Women's Health Conditions | NCT00090389 | Ovarian Neoplas... Endometriosis Pelvic Pain Uterine Neoplas... | Chinese Acupunc... | 18 Years - | National Center for Complementary and Integrative Health (NCCIH) | |
| Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent | NCT00361036 | Leiomyoma Leiomyomatosis Uterine Neoplas... | Uterine fibroid... Uterine fibroid... | 30 Years - 50 Years | Worthington-Kirsch, Robert L., M.D. | |
| ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy. | NCT04063072 | Uterine Neoplas... | ERAS protocol | 18 Years - | Ospedale Regina Montis Regalis | |
| SMS-based Summons in Cervical Screening | NCT04061967 | Cervical Cancer Uterine Cervica... Uterine Neoplas... Genital Neoplas... Genital Neoplas... Uterine Disease... Genital Disease... Neoplasms by Si... Neoplasms Uterine Cervica... | Sending of scre... | 33 Years - 75 Years | Karolinska Institutet | |
| ChemoFx® PRO - A Post-Market Data Collection Study | NCT00669422 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... Uterine Neoplas... Endometrial Can... Vaginal Cancer Vulvar Cancer Cervical Cancer | 18 Years - | Precision Therapeutics | ||
| Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients | NCT02374411 | Pseudomyxoma Pe... Appendiceal Neo... Pancreatic Neop... Neoplasm Metast... Adenocarcinoma Sarcoma Uterine Neoplas... | - | Edward-Elmhurst Health System | ||
| Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy | NCT00505492 | Uterine Neoplas... | Carboplatin Cisplatin Paclitaxel | - | M.D. Anderson Cancer Center | |
| Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients | NCT02444195 | Uterine Cervica... Uterine Neoplas... Ovarian Neoplas... Urogenital Neop... Fallopian Tube ... | Guided Imagery ... | 18 Years - | University of Michigan | |
| Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer | NCT01650376 | Stage III Ovari... Stage IV Ovaria... Uterine Cancer | Olaparib Carboplatin Paclitaxel | 18 Years - | Swedish Medical Center | |
| Pre-Clinical Models in Gynecological Tumors A Tissue Repository | NCT00250783 | Endometrial Neo... Uterine Neoplas... | 18 Years - | University of New Mexico | ||
| Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] | NCT03555422 | Endometrial Can... | Selinexor Matching placeb... | 18 Years - | Karyopharm Therapeutics Inc | |
| MRI and Metabolomics Biomarkers for Uterine Malignancy | NCT02528864 | Uterine Neoplas... | 20 Years - 80 Years | Chang Gung Memorial Hospital | ||
| A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer | NCT01654458 | Sexual Dysfunct... Uterine Cervica... Ovarian Neoplas... Uterine Neoplas... Genital Neoplas... | GyneGals Suppor... | 18 Years - | Women's College Hospital | |
| A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | NCT00628901 | Leiomyoma Uterine Fibroid... Uterine Neoplas... Menorrhagia Leiomyomatosis | Uterine Fibroid... Contour SE™ Mic... Embosphere® Mic... | 18 Years - | Boston Scientific Corporation | |
| A Trial for Patients With Advanced/Recurrent Endometrial Cancer | NCT00377520 | Neoplasms Neoplasms by Si... Urogenital Neop... Genital Neoplas... Uterine Neoplas... Endometrial Neo... Cancer of Endom... Endometrial Can... Cancer of the E... Endometrium Can... Neoplasms, Endo... | pemetrexed | - | Eli Lilly and Company | |
| Impact of the COVID-19 Pandemic in Gynecological Oncology | NCT04351139 | Gynecologic Can... Breast Neoplasm... Uterine Neoplas... Ovarian Neoplas... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... | modification of... | 18 Years - | Hospices Civils de Lyon | |
| Sentinel Node Mapping in Women With Endometrial and Cervical Cancer | NCT02820506 | Uterine Cervica... Uterine Neoplas... | SLN mapping and... | 18 Years - | University of Southern Denmark | |
| Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology | NCT01969396 | Menorrhagia Endometrial Neo... Polycystic Ovar... Uterine Neoplas... | SonoBiopsy Cath... Endometrial bio... | 18 Years - | Cook Group Incorporated | |
| Self-Hypnotic Relaxation Therapy During Invasive Procedures | NCT00087841 | Uterine Neoplas... Leiomyoma | Self-hypnotic r... | 18 Years - 90 Years | National Center for Complementary and Integrative Health (NCCIH) | |
| Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications | NCT02865889 | UTERINE CERVICA... ENDOMETRIAL NEO... | Laparoscopy in ... Conventional su... | 18 Years - | Institut Paoli-Calmettes | |
| A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study | NCT01271959 | Solid Organ Tum... | 18 Years - | Precision Therapeutics | ||
| Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids | NCT00100191 | Menorrhagia Leiomyoma Uterine Neoplas... | uterine artery ... hysterectomy | 18 Years - | ZonMw: The Netherlands Organisation for Health Research and Development | |
| Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent | NCT00361036 | Leiomyoma Leiomyomatosis Uterine Neoplas... | Uterine fibroid... Uterine fibroid... | 30 Years - 50 Years | Worthington-Kirsch, Robert L., M.D. | |
| Sentinel Node Biopsy in Endometrial Cancer | NCT01564264 | Uterine Neoplas... Sentinel Lymph ... | Sentinel Lymph ... | 18 Years - | Hamilton Health Sciences Corporation | |
| ChemoFx® PRO - A Post-Market Data Collection Study | NCT00669422 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... Uterine Neoplas... Endometrial Can... Vaginal Cancer Vulvar Cancer Cervical Cancer | 18 Years - | Precision Therapeutics | ||
| Sentinel Node Mapping in Women With Endometrial and Cervical Cancer | NCT02820506 | Uterine Cervica... Uterine Neoplas... | SLN mapping and... | 18 Years - | University of Southern Denmark | |
| Biobehavioral Intervention in Gynecologic Oncology Patients | NCT02454036 | Neoplasms Ovarian Neoplas... Uterine Neoplas... Vulva | BBI interventio... | 21 Years - 80 Years | University of Kentucky | |
| A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | NCT00628901 | Leiomyoma Uterine Fibroid... Uterine Neoplas... Menorrhagia Leiomyomatosis | Uterine Fibroid... Contour SE™ Mic... Embosphere® Mic... | 18 Years - | Boston Scientific Corporation | |
| Retrospective Study of Brachytherapy | NCT05242861 | Brachytherapy Uterine Cervica... Uterine Neoplas... Vulvar Cancer Vaginal Cancer Ovarian Neoplas... Gynecologic Neo... | Brachytherapy | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
| Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial | NCT04679675 | Uterine Cervica... Uterine Neoplas... Genital Neoplas... Urogenital Neop... Neoplasms by Si... Neoplasms Uterine Cervica... Uterine Disease... Cervical Cancer Cervical Dyspla... Human Papilloma... HPV-Related Cer... HPV Infection HPV-Related Mal... | Usual Care Education Direct Mail Opt-in | 30 Years - 64 Years | Kaiser Permanente | |
| SMS-based Summons in Cervical Screening | NCT04061967 | Cervical Cancer Uterine Cervica... Uterine Neoplas... Genital Neoplas... Genital Neoplas... Uterine Disease... Genital Disease... Neoplasms by Si... Neoplasms Uterine Cervica... | Sending of scre... | 33 Years - 75 Years | Karolinska Institutet | |
| Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis | NCT00250770 | Uterine Neoplas... Endometrial Neo... | - | University of New Mexico | ||
| Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications | NCT02865889 | UTERINE CERVICA... ENDOMETRIAL NEO... | Laparoscopy in ... Conventional su... | 18 Years - | Institut Paoli-Calmettes | |
| Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients | NCT02374411 | Pseudomyxoma Pe... Appendiceal Neo... Pancreatic Neop... Neoplasm Metast... Adenocarcinoma Sarcoma Uterine Neoplas... | - | Edward-Elmhurst Health System | ||
| Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2) | NCT00188578 | Cervix Neoplasm... Uterine Neoplas... Vaginal Neoplas... | Intensity Modul... | 18 Years - | University Health Network, Toronto | |
| Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer | NCT00782041 | Uterine Neoplas... | Oxaliplatin 5-FluoroUracil Folinic acid | 18 Years - | Sanofi | |
| ChemoFx® PRO - A Post-Market Data Collection Study | NCT00669422 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... Uterine Neoplas... Endometrial Can... Vaginal Cancer Vulvar Cancer Cervical Cancer | 18 Years - | Precision Therapeutics | ||
| A Trial for Patients With Advanced/Recurrent Cervical Cancer | NCT00190983 | Cervical Intrae... Uterine Neoplas... Genital Neoplas... | Pemetrexed | - | Eli Lilly and Company | |
| Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations | NCT04579380 | Uterine Neoplas... Uterine Cervica... Biliary Tract N... Urologic Neopla... Carcinoma, Non-... HER2 Mutations ... | tucatinib trastuzumab fulvestrant | 18 Years - | Seagen Inc. | |
| Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis | NCT00250770 | Uterine Neoplas... Endometrial Neo... | - | University of New Mexico | ||
| Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma | NCT00050440 | Endometrial Neo... Uterine Neoplas... Genital Neoplas... | Trabectedin Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer | NCT03951415 | Endometrial Neo... Uterine Neoplas... Endometrium Can... | PARP inhibitor ... | 18 Years - | Leiden University Medical Center | |
| ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy. | NCT04063072 | Uterine Neoplas... | ERAS protocol | 18 Years - | Ospedale Regina Montis Regalis | |
| Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial | NCT04679675 | Uterine Cervica... Uterine Neoplas... Genital Neoplas... Urogenital Neop... Neoplasms by Si... Neoplasms Uterine Cervica... Uterine Disease... Cervical Cancer Cervical Dyspla... Human Papilloma... HPV-Related Cer... HPV Infection HPV-Related Mal... | Usual Care Education Direct Mail Opt-in | 30 Years - 64 Years | Kaiser Permanente | |
| A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer | NCT01654458 | Sexual Dysfunct... Uterine Cervica... Ovarian Neoplas... Uterine Neoplas... Genital Neoplas... | GyneGals Suppor... | 18 Years - | Women's College Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
